FDA responds to Civil Service Compensation Scheme proposals


FDA members affected by changes to the CSCS will have seen the union's update email informing them of next steps, following the Cabinet Office announcement of its proposals for new redundancy compensation terms and arrangements on 26 September.

This follows three months of intensive negotiations between the Government and the FDA, alongside Prospect, Unison, GMB, and the Defence Police Federation - the unions that, together with the FDA, agreed to continue negotiating following the Government's initial offer in June 2016 and which represent a broad spectrum of civil servants.

The Cabinet Office has also set out an alternative scheme; a revised set of terms that will apply if an insufficient number of unions agree to the terms.

Responding to the Cabinet Office proposals, FDA General Secretary Dave Penman told Civil Service World that the Government had "failed to give a coherent explanation of why further radical changes in the value of civil service redundancy payments are necessary" and had "rejected all representations to think again and made clear that they would proceed regardless".

However, he defended the union's decision to enter negotiations: "The choice facing the FDA was whether to stand on the side-lines complaining about the injustice of further reductions in these payments, or to engage in negotiations with a view to getting the best possible deal for members," he said.

"The FDA has taken the latter course, as it did in 2010, and together with other unions has negotiated a package which, whilst not ideal, will limit much of the unfairness of the Government's more radical intentions and indeed improves the scheme in some areas."